CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Cobalis Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Cobalis Corporation
2445 McCabe Way
Suite 200
Phone: 949-757-0001p:949-757-0001 Irvine, CA  92614  United States Ticker: CLSCCLSC
This company is no longer actively traded on any major stock exchange.
Business Summary
Cobalis Corp. (Cobalis) is a development stage company. It is a specialty pharmaceutical company focused in the development and United States Food and Drug Administration approval of PreHistin, an over-the-counter drug product candidate intended to treat seasonal allergy suffers. As of March 31, 2007, the Company was reviewing its PreHistin clinical trial data. During the fiscal year ended March 31, 2007, PreHistin is in Phase III development for its initial indication for seasonal allergies. In August 2009, the Company filed Chapter 11 five year reorganization plan and disclosure statement.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20073/31/2007YesYesYes--

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board RadulRadovich 84 1/1/2004
President, Secretary ChaslavRadovich 47 2/20/2007 1/1/2003
Interim Chief Financial Officer, Treasurer Kevin F.Pickard 47 12/16/2006 12/16/2006
6 additional Officers and Directors records available in full report.

Business Names
Business Name
Biogentech Corp
CLSC
Cobalis Corporation
TOGS FOR TYKES INC

General Information
Number of Employees: 5 (As of 3/31/2007)
Outstanding Shares: 50,865,128 (As of 3/21/2008)
Shareholders: 276
Stock Exchange: OTC
Federal Tax Id: 911868007
Fax Number: 949-757-0001


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023